The dystrobrevin-binding protein 1 (DTNBP1) gene on chromosome 6p has emerged as a potential susceptibility gene for schizophrenia. Although a number of attempts to replicate the original association finding have been successful, they have not identified any obvious pathogenic variants or a single at risk haplotype common to all populations studied. In the present study we attempted further replication in an independent sample of 638 nuclear families from the Han Chinese population of Sichuan Province, SW China. We also examined 580 Scottish schizophrenic cases and 620 controls. We genotyped 10 single-nucleotide polymorphisms (SNPs) in DTNBP1 that were used in the original report of association, plus rs2619538 (SNP 'A') in the putative promoter region, which has also been associated with schizophrenia. In the Chinese trios we found that two SNPs (P1635 and P1765) were significantly overtransmitted, but with alleles opposite to those reported in the original studies. SNPs P1757 and P1765 formed a common haplotype, which also showed significant overtransmission. In the Scottish cases and controls, no individual markers were significantly associated with schizophrenia. A single haplotype, which included rs2619538 and P1583, and one rare haplotype, composed of P1320 and P1757, were significantly associated with schizophrenia, but no previously reported haplotypes were associated. Based on the data from the Chinese population, our results provide statistical support for DTNBP1 as a susceptibility gene for schizophrenia, albeit with haplotypes different from those of the original study. However, our lack of replication in the Scottish samples also indicates that caution is warranted when evaluating the robustness of the evidence for DTNBP1 as genetic risk factor for schizophrenia. Molecular Psychiatry (2005Psychiatry ( ) 10, 1037Psychiatry ( -1044Psychiatry ( . doi:10.1038 published online 26 July 2005 Keywords: psychosis; association; 6p; dysbindin; dystrobrevin Schizophrenia is a debilitating brain disease that affects up to 1% of the population worldwide. There is no cure and treatments, which are mainly based on antagonism of dopamine, serotonin and other neurotransmitter receptors in the brain, are only partially effective. Although the aetiology of schizophrenia is not well understood, there is longstanding evidence of a genetic component, and recent twin studies place the heritability of schizophrenia at more than 80%.
Schizophrenia is a debilitating brain disease that affects up to 1% of the population worldwide. There is no cure and treatments, which are mainly based on antagonism of dopamine, serotonin and other neurotransmitter receptors in the brain, are only partially effective. Although the aetiology of schizophrenia is not well understood, there is longstanding evidence of a genetic component, and recent twin studies place the heritability of schizophrenia at more than 80%. 1 Linkage analysis has identified several loci, including chromosome 8p, 13q, 22q and 6p. [2] [3] [4] The gene dystrobrevin-binding protein 1 (DTNBP1), which maps to chromosome 6p, has emerged as a susceptibility factor for schizophrenia. [5] [6] [7] [8] [9] [10] [11] It is a widely expressed small coiled-coil protein that was originally identified in a screen for proteins that interact with alpha-and beta-dystrobrevin. 12 It causes a single gene disorder, the bleeding and pigmentation disorder Hermansky-Pudlak syndrome type 7. 13 Dysbindin is also dysregulated in muscular dystrophy, and its role in this disease is supported by animal models. 14 In addition to its role as dystrobrevinbinding protein, it is involved in protein trafficking and organelle biosynthesis through a soluble 200-kDa protein complex, the biogenesis of lysosome-related organelles complex-1 (BLOC-1), and it binds directly to the proteins pallidin and muted. 13, 15 It is also apparent that dysbindin has tissue-specific ligands that may play important roles in the different disease states involving this protein. 12 In the brain it binds to beta-dystrobrevin, and it is expressed in several different locations, including axon fibres in the corpus callosum and mossy fibre terminal fields in the hippocampus. It is involved in signal transduction through clustering of nicotinic and NMDA receptors, but little else is known about its CNS function and it is an unlikely candidate gene for schizophrenia. Analysis subsequent to its putative identification as a susceptibility gene for schizophrenia indicates that it induces the expression of two presynaptic proteins, SNAP25 and synapsin I, and increases extracellular basal glutamate levels, whereas reduced expression has the converse effect. This suggests that DTNBP1 influences exocytotic glutamate release via modulation of presynaptic machinery. 16 The DTNBP1 locus at 6p24-21 was originally identified from multipoint linkage analysis of Irish high-density pedigrees, 17, 18 and has been supported by results from several other linkage studies (reviewed in Riley and McGuffin 2 ) and meta-analyses. 4 Fine mapping of this region identified several singlenucleotide polymorphisms (SNPs) within the 140-kb DTNBP1 gene, which were strongly associated with schizophrenia.
8 Subsequent attempts at replicating this finding identified association with the alleles opposite to those reported by the initial study of a different, very common dysbindin haplotype in German and Israeli families. 7 Further analysis in the original associated Irish sample suggested a simple structure where the linkage disequilibrium (LD) in the target region could be explained by six haplotypes that together accounted for 96% of haplotype diversity, and from these a single 30 kb long, uncommon (6%) high-risk haplotype was identified that showed a significant association with schizophrenia and explained the pattern of significant findings in the analyses with individual markers. 10 Similar findings were reported in the US population by Funke et al. 5 In Han Chinese, 9 the original haplotype was not associated with schizophrenia but the most common haplotype showed strong association. Van Den Bogaert (2003) 19 found association with yet other haplotypes in Swedish and German families. No association with the original region was reported by Morris et al 20 and Williams et al, 11 while multiple novel haplotypes spanning a putative promoter region were associated in these two independent sample sets. 11 Kohn et al 21 identified microsatellite marker haplotypes at the DTNBP1 locus, which were significantly associated with schizophrenia from an isolated population in Israel, while Numakawa et al 16 identified strong association with a multimarker SNP haplotype in a Japanese population. A high-risk haplotype found in that study is a subhaplotype of a risk haplotype identified in the Irish population. 10 These genetic studies are supported by two papers describing reduced levels of expression of Dysbindin in postmortem brains of schizophrenics. 22, 23 These series of studies provide evidence for global association between DTNBP1 and schizophrenia, but the patterns of LD reported are complex and inconsistent and no specific pathogenic variants have been identified. In the present study we attempted further replication in an independent sample of 638 nuclear families from the Han Chinese population of Sichuan Province, SW China, and 580 Scottish schizophrenics and 620 controls.
Materials and methods

Subjects
Chinese subjects In total, 638 nuclear families were collected from the Han Chinese population of Sichuan Province, SW China. Three sets of samples were collected in three phases. The first sample comprises 308 family trios consisting of schizophrenic patients and both their parents. The second sample comprises 139 schizophrenic sibling pair families with one or both parents included. Detailed information about the two sets of samples is described elsewhere. 24, 25 The third sample consists of 191 nuclear families with one or more affected offspring, which includes 206 schizophrenic patients, 262 of their parents and eight affected siblings. Aside from ascertainment criteria of having an affected sibling for the second sample, all samples and data were collected using the same methods and from the same geographic region by a single team of clinical psychiatrists (supervised by TL and XL). Since there is no reason to suppose that there is ethnic stratification or diagnostic differences between the three samples, they were combined for the purpose of transmission distortion analysis. All subjects were interviewed by a trained psychiatrist using the SCID. Diagnosis of schizophrenia was assigned on the basis of the interview and medical records according to DSM-III-R or DSM-IV criteria. Age at the onset of psychosis was determined by the patients' self-report of the onset of illness corroborated by medical records and the use of informants wherever possible. The sample consisted of 444 males and 366 females with schizophrenia. Genomic DNA was extracted from peripheral blood according to a standard phenol-chloroform procedure. Informed consent was obtained from all participants, and the study was approved by the ethical committee of the South London and Maudsley Trust (SLAM), and by West China University of Medical Sciences (now Sichuan University).
Scottish Subjects (n ¼ 580) All were recruited through Scottish psychiatric hospitals and met DSM111R or DSM1 V criteria for schizophrenia or schizoaffective disorder. Consensus diagnosis was made by two consultant psychiatrists based on a combination of examination of psychiatric case notes and clinical interview. Subjects were 72% male and 28% female. Controls (n ¼ 620) were recruited via Scottish blood transfusion service from the same region of Scotland and were 57% male and 43% female. Subjects and controls have been previously described. 26 Multiregional Ethics Committee (MREC) approval was granted for this study.
Genotyping A total of 10 DTNBP1 SNPs were analysed (P1583, P1578, P1763, P1320, P1757, P1765, P1325, P1635, P1655 and P1287) from the study of Straub et al. 8 An 11th SNP, SNP 'A' (rs2619538), described by Williams et al 11 in a putative promoter region of DTNBP1 was also genotyped. This allowed us to define three marker haplotypes involving rs2619538, P1635 and P1655, which were strongly associated with schizophrenia in the Welsh/English population and modestly associated in the Irish population. 11 We initially performed validation genotyping in all these SNPs in 94 Chinese controls to test if they are polymorphic in this population. SNPs P1578 and P1287 were monomorphic in the Han Chinese, and so these SNPs were only included in the analysis of the Scottish data. All genotyping was performed blind to status by K-Biosciences (Herts, UK) (http://www. kbioscience.co.uk/) using a competitive allele-specific PCR system (CASP). Quality control criteria were that genotypes form three distinct clusters, water controls were negative, number of genotypes callable was 490% and minor allele frequency was greater than 2%. In addition, interplate and intraplate duplicate testing of known DNAs was performed. All genotyping was performed sequentially by the same method.
Statistical analysis
Linkage disequilibrium between the SNPs was estimated using program LDMAX. 27 The statistical association R 2 was used to measure LD between markers. 28 The program package UNPHASED was used to test the LD between the individual marker locus or haplotypes and the hypothetical disease locus. 29 PDTPHASE and TDTPHASE were used in family data analysis. PDTPHASE is an implementation of the pedigree disequilibrium test with extensions to deal with haplotypes and missing data. It is suitable for use with both family trio and sibling pair sample structures, and is more conservative. The frequencies of the transmitted/not-transmitted allele were derived from TDTPHASE. COCAPHASE, which is a method of standard unconditional logistic regression, was used for case-control data.
Permutation correction was performed using 1000 permutations for programs PDTPHASE and COCA-PHASE. This corrects for multiple testing but accounts for correlation between markers, so is less conservative than a Bonferroni correction, which is appropriate for independent tests such as unlinked markers. To perform the permutation test, the 'transmitted' and 'untransmitted' labels are reassigned, with the same assignment used for all possible haplotype assignments. In each replicate, all the selected markers are analysed and the most significant P-value stored, so that the permutation procedure gives a significance level corrected for the multiple haplotypes and markers tested. PDTPHASE and COCAPHASE program only give the corrected Pvalue for the most significant P-values. Permutation correction operates for each specified set of markers used to create haplotypes but does not correct for different sets of markers, for example, to examine subhaplotypes; thus, for example, examining two-, three-and four-marker haplotypes would involve a degree of multiple testing that is not corrected for by this method.
Results
Hardy-Weinberg equilibrium and LD Of the 11 polymorphisms tested, SNPs P1287 and P1578 were found to be monomorphic in the Chinese population, and were discarded after validation tests. All 11 SNPs were polymorphic in the Scottish population and included in the analysis. The genotypic frequencies of all SNPs were in Hardy-Weinberg equilibrium in the Chinese unrelated parents and in the Scottish controls except rs2619538, which deviated from HWE in both the Chinese unrelated parents and affected offspring (each Po0.001), despite passing quality control procedures and showing Mendelian inheritance. Consequently, we dropped this marker from the analysis in the Chinese population. We have no obvious explanation for this HWE deviation. Aside from genotyping errors, one explanation is that there is another SNP polymorphism not present in the Scottish sample under one of the two primers or the probe used in the assay, which produces a genotyping artifact. LD arrangements (R 2 ) for the Chinese and Scottish samples are displayed in Table 1 . In the Chinese sample we only observed strong or medium LD between SNPs P1763, P1320 and P1757 and SNPs P1583 and P1655. In the Scottish sample, P1578 was also in moderate LD with P1757, P1320 and P1763. A haplotype block involving P1763, P1320, P1757 and P1765 was present in both populations, but because two of the markers (P1578 and P1287) are monomorphic in the Chinese population, the overall set of haplotypes present differs between the two groups. Table 2 compares transmitted and nontransmitted allele frequencies in Chinese trios, and allele frequencies in Scottish cases and controls. PDTPHASE showed significant overtransmission of the most common alleles of SNPs P1765 and P1635 in the Chinese trios. No significant differences were found in allele frequencies between the Scottish cases and controls for all eleven markers examined.
Individual DNTBP1 SNPs
Haplotype analysis
We performed moving-window haplotype analysis for two-and three-marker on all SNPs examined. The two window results are shown in Table 3 . In the Chinese Identifying potential risk haplotypes for schizophrenia T Li et al trios, two-marker haplotype analysis showed that haplotype P1757G-P1765G was highly significantly overtransmitted (Z ¼ 4.55, P ¼ 0.000005; o0.001 after permutation correction by 1000 simulations). For three-marker analysis, there was significant transmission distortion for the two haplotypes 1757G-P1765A-P1325C (Z ¼ 3.42, P ¼ 0.0007; 0.01 after permutation correction) and P1320T-P1757G-P1765G (Z ¼ 2.05, P ¼ 0.04; not significant after permutation correction) in schizophrenia (data not 
Note that since rs2619538 deviated from HWE in the Han Chinese, it was dropped from the analysis for that population.
-denotes not analysed, marker monomorphic or not in HWE. Dotted lines denote diagonal of chart. T: transmitted; NT: not transmitted; P-value in parenthesis was the best P-value, which was corrected for multiple tests after 1000 permutations. Note that since rs2619538 deviated from HWE in the Han Chinese, it was dropped from the analysis for that population.
Identifying potential risk haplotypes for schizophrenia T Li et al shown). The P1655-P1635-rs2619538 (SNP A) haplotype reported as associated with schizophrenia in the Welsh/English and Irish cases and controls 11 was dropped from the analysis in the Chinese sample, as were all other haplotypes containing rs2619538 (SNP A). There was no significant transmission distortion in the Chinese population (global P ¼ 0.31) when including all remaining SNPs for the haplotype analysis (data not shown). The results of our haplotype analysis indicate that the region between SNPs P1325 and P1320 may be responsible for the DTNBP1 gene conferring risk of schizophrenia in the Chinese population. The markers in this region of DTNBP1 were not typed in the study of Chinese trios by Tang et al, 9 and so the two studies cannot be directly compared.
In the Scottish sample, two marker haplotype analyses using a sliding window showed significant evidence for association with the rare haplotype P1320C-P1757A (0.03 vs 0.01; P ¼ 0.0006 uncorrected) and also significant association with haplotype rs2619538A-P1583T (0.08 vs 0.013, P ¼ 0.003 uncorrected) (Table 3) . However, only the former of these results remains significant after permutation correction. For three marker analysis, haplotype P1757G-P1765G-P1325C was associated, with a frequency of 0.66 in cases and 0.71 in controls (P ¼ 0.01; not significant after permutation correction). Two pairs of markers forming these associated haplotypes (P1320-P1757 and P1757-P1765) are in strong LD with each other (R 2 40.8), which is taken account of in the permutation correction analysis. All P-values shown are uncorrected by permutation testing, which we use to take account of the linkage disequilibrium between markers forming the haplotypes; *Po0.001 after permutation.
Identifying potential risk haplotypes for schizophrenia T Li et al
Haplotypes involving rs2619538-P1583-P1578 showed a significant global P-value of 0.02. The haplotype rs2619538A-P1583T-P1578C was significantly reduced, with a frequency of 0.08 in cases and 0.13 in controls (P ¼ 0.003); however, again this would not be significant after permutation correction.
Examination of the Williams 11 protective haplotype rs2619538A-P1635A-P1655C failed to show evidence of reduction in the Scottish schizophrenics, and indeed the AAC haplotype was slightly increased compared to controls. By contrast, the rs2619538A-P1635A-P1655G haplotype was significantly underrepresented in the Scottish schizophrenics compared to the control population (0.08 of cases and 0.12 of controls, w 2 ¼ 7.38, P ¼ 0.007), but again this would not be significant after permutation correction. There was no significant association in the Scottish population (global P ¼ 0.16) when including all SNPs for the haplotype analysis (data not shown).
Discussion
In the present study, we attempted to replicate findings of association between the dysbindin gene and schizophrenia in samples from Scotland and the UK. For the Scottish sample, we would consider a fully successful replication to be the demonstration of association with the same haplotype pattern as that seen in the original studies of the Irish high-density studies, with significance lower than P ¼ 0.05. We would consider replication of other findings of association, that is, those with different haplotypes, a partial success. For the Chinese sample, we cannot necessarily expect to find a direct replication of the original haplotype association as the pattern and frequency of haplotypes in the Han Chinese may be very different from those seen in Europeans; however, any positive findings, given the necessity to consider the number of statistical tests we perform and the context of other dysbindin association studies in the same geographic population, would provide general support for a role of dysbindin in schizophrenia.
In the Chinese sample, we find a highly significant overtransmission of the more frequent alleles for markers P1765 and P1635 individually. This contrasts with Straub et al 8 and Van den Oord et al, 10 who found the rare alleles overtransmitted, and accords with Schwab et al 7 and Kirov et al, 6 who also found overtransmission of the common alleles. Two and three marker haplotype analysis of the region using a sliding window also agrees with these latter studies, and shows overtransmission of haplotypes containing the more frequent alleles. The markers in this region of DTNBP1 were not typed in the study of Chinese trios by Tang et al, 9 and so the two studies cannot be directly compared. Unfortunately, the marker rs2619538 (SNP A) 11 was not in HWE in the Chinese Han population and so was dropped from the analysis. This SNP maps to a repetitive region with Alu-repeat sequences and so may contain additional variation in the Chinese population.
Overall, the Chinese sample showed evidence for transmission distortion of certain dysbindin single marker alleles and haplotypes that would survive even conservative (for example, 20-fold) correction for multiple testing. These findings are not likely to result from genotyping error or population stratification, as we employed quality control criteria and the sample is family based, and the level of significance means that occurrence by chance alone is also unlikely.
The Scottish data are similar to the Irish 19 and Welsh/English 11 case/control studies and show no significant differences in allele frequency in any of the markers originally reported as associated in the Irish by Straub et al. 8 Moreover, the allele frequencies are broadly similar across the three countries. Three marker haplotype analyses using sliding window show modest under-representation of the common haplotype P1757G-P1765G-P1325C. These differences would not be significant after correction for multiple testing. However, a rare haplotype (P1320C-P1757A) does remain significantly enriched after correction. The broad conclusion must be drawn that three case/control studies from Irish, Welsh/English and Scottish populations have not found significant enrichment for any individual alleles or haplotypes originally reported in the Irish population by Straub et al 8 and Van den Oord et al. 10 The sample sizes of these studies are substantial and inadequate power is unlikely to explain these negative observations.
The present study has several limitations. Firstly, there is a limitation on the haplotype analysis, since multigenerational families are required to properly assign haplotypes and we used a family trios and case-control design. Thus, it was necessary for us to impute haplotypes from allele frequencies, which could result in false-negative or false-positive results. Secondly, there could be sex differences in association between dysbindin and schizophrenia; however, we have chosen not to analyse the data by sex because of lack of prior evidence of a sex difference in association and the fact that we would introduce further multiple testing.
Thirdly, a difference in 'genetic loading' or the relative contribution of genetic effects to schizophrenia in the subjects might also be important. Generally, a family history of the psychosis is much less common in cases from unselected population-based association studies compared to those in family linkage studies, which by definition have affected relatives. Van Den Bogaert et al (2003) 19 discussed this potential limitation and found that the dysbindin gene was more strongly associated with schizophrenia when a family history of the disease was present. However, family history of the disease does not necessarily correlate with genetic loading, as seen in recessive single-gene diseases, where affected relatives are often absent. Furthermore, twin studies of schizophrenia, which show heritability of 480%, do not select proband twins for having a positive family history, but still provide evidence for a very strong genetic component to the disease. In our view, the validity of analysing patients with a family history vs those without is not clear and introduces multiple testing and thus the potential for false positive results. People without a family history may simply have fewer identified relatives, making it difficult to assess their genetic loading, and there is no evidence from genetic epidemiology that their disease should be less genetic.
The case for DTNBP1 as a susceptibility gene for schizophrenia is strong but not unassailable. While almost all studies (including this one), which have examined the gene using a large set of markers, have obtained some significant transmission distortion or association using the original set of markers, it is of concern that, with the exception of Funke et al, 5 none of these represent a direct replication. Furthermore, novel markers, which were later reported to show association, show similar inconsistencies across samples, and pathogenic alleles have not been identified. Thus, our study has failed to confirm the protective effect of carrying the novel rs2619538A-P1635A P1655C haplotype in a Caucasian population, as reported by Williams et al. 11 By contrast another haplotype (rs2619538A-P1635A-P1655G) is significantly under-represented in the Scottish schizophrenics compared to controls. Even if more than one functional variant is present in or close to the DTNBP1 gene as with NOD 2/CARD 15 gene and Crohn's disease, 30 one might expect at least one of these large follow-up studies to have findings similar to those originally reported by Straub et al. 8 This variable pattern of haplotype association is difficult to interpret. However, since the schizophrenia-associated haplotypes are presumably surrogates for underlying and as yet undetected causative polymorphism(s), and given that there may be considerable stratification between ethnically similar populations such as the Irish, Scottish, Welsh and English, and indeed within supposedly isolated populations, 31 variable haplotype association cannot simply be taken as inconsistent with a role for dysbindin in the disease. There are, however, likely to be pitfalls in the haplotype approach to association in complex diseases, perhaps because of the sensitivity of haplotype frequencies to population stratification and the effect of genotyping errors on inflating evidence for association. 32 A simple explanation for all these contradictory results could of course emerge if functional variants conferring risk were to be identified at or near DTNBP1 gene. DTNBP1 is a large complex gene with four putative promoters and several alternatively spliced exons. Unless this happens, and without further robust functional evidence, a role for dysbindin in susceptibility to schizophrenia remains strong but circumstantial.
